Streetbeat News

Products Services

NUWE

Nuwellis has filed a new patent application for an 'Extracorporeal Blood Filtering Machine and Methods for Renal Replacement Therapy'. This development could enhance their product offerings in the medical device sector.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 6:30 pm

HIMS

IBUY

PTH

Needham analyst Ryan Macdonald initiated coverage on Hims & Hers Health Inc. (NYSE:HIMS) with a Buy rating and a $24 price target, citing growth potential in the weight loss market. HIMS is expected to benefit from its entry into the GLP-1 market and other growth drivers. The company reported strong earnings and revenue, exceeding analyst expectations.

Portfolio Pulse from Lekha Gupta

August 22, 2024 | 6:26 pm

ETHA

MSTX

Bloomberg ETF analysts discuss the growth and challenges of cryptocurrency ETFs, highlighting Bitcoin ETFs' significant inflows and Ethereum ETFs' struggles. They also mention the volatility of leveraged MicroStrategy ETFs.

Portfolio Pulse from Khyathi Dalal

August 22, 2024 | 6:21 pm

EYEN

Eyenovia Inc (NASDAQ:EYEN) stock is trading higher after a significant drop, with a session volume much higher than average. The company announced a share offering to raise approximately $5.14 million, which will be used for product commercialization, clinical studies, and potentially repaying loans. The stock price increased by 11.8% following this news.

Portfolio Pulse from Vandana Singh

August 22, 2024 | 6:20 pm

META

Instagram, owned by Meta Platforms, is introducing a new feature allowing users to add a favorite song to their profile, reminiscent of Myspace's functionality. This move aims to enhance user engagement and nostalgia.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 6:13 pm

MRNA

Moderna announced that its updated Covid-19 vaccine, targeting the KP.2 variant, will be available in U.S. pharmacies and care settings in the coming days.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 6:07 pm

NVAX

Novavax is collaborating with the U.S. FDA to secure authorization for its 2024-2025 formula Covid-19 vaccine. The company anticipates receiving approval in time for the peak vaccination season.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 6:04 pm

FUBO

FuboTV Inc. has launched BKFC TV, the first free ad-supported streaming TV channel from Bare Knuckle Fighting Championship, expanding its sports content offerings.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 6:01 pm

AMD

NVDA

QQQ

SMCI

SPY

Super Micro Computer (SMCI) stock is trading lower due to a broader semiconductor selloff, despite strong growth and potential in AI servers. Nvidia and AMD, key clients, are also affected. The AI server market is expected to grow significantly, benefiting companies like SMCI.

Portfolio Pulse from Anusuya Lahiri

August 22, 2024 | 5:53 pm

BIIB

Biogen's Alzheimer's drug, Leqembi, has been approved by the UK's Medicines and Healthcare products Regulatory Agency. However, the National Institute for Health and Care Excellence (NICE) does not recommend it for NHS reimbursement due to cost-effectiveness concerns. Despite showing a small benefit in slowing disease progression, the drug's high costs and limited long-term evidence are barriers.

Portfolio Pulse from Vandana Singh

August 22, 2024 | 5:45 pm